Skip to main content
. 2005 Oct 6;34(2):142–150. doi: 10.1165/rcmb.2005-0130OC

TABLE 1.

FEATURES OF MALIGNANT PLEURAL EFFUSIONS GENERATED IN C57B/6 MICE 14 d AFTER INTRAPLEURAL INJECTION OF 15 × 105 LLC CELLS (n = 9) COMPARED WITH UNTREATED MICE (n = 5).

Features Untreated Mouse Mouse MPE
Pleural fluid volume, μl 16.2 ± 1.4 667 ± 58
Pleural surface tumor number 0 8.6 ± 1.0
Red blood cells, ×103/μl
 Pleural fluid 0 4.7 ± 0.55
 Blood 8.2 ± 0.7 8.4 ± 0.15
Nucleated cells, ×103/μl
 Pleural fluid 0.5 ± 0.2 32.7 ± 4.5
 Blood 6.5 ± 1.3 8.0 ± 0.6
Pleural fluid tumor cells, ×103/μl 0 14.7 ± 2.9
Pleural fluid cells, % of nontumor cells
 Mononuclear 72 ± 12 57 ± 5
 Lymphocytes 22 ± 5 23 ± 6
 Neutrophils 5 ± 3 13 ± 4
 Eosinophils 1 ± 1 12 ± 2
 Basophils Occasional Occasional
Glucose, mg/dl
 Pleural fluid 167 ± 15 208 ± 55
 Serum 87 ± 5 214 ± 73
Protein, g/dl
 Pleural fluid 1.07 ± 0.1 2.18 ± 0.03
 Serum 1.76 ± 0.31 1.67 ± 0.15
 Ratio 0.6 ± 0.06 1.37 ± 0.14
LDH, U/l
 Pleural fluid 1,204 ± 105 6,850 ± 1,170
 Serum 995 ± 204 1,213 ± 147
 Ratio 1.21 ± 0.12 5.57 ± 0.62
VEGF, pg/ml
 Pleural fluid 88 ± 52 2,303 ± 284
 Serum 64 ± 47 47 ± 29
Vascular hyperpermeability, pleural fluid/serum Evan's blue No (< 1%) Yes (26 ± 9%)

Definition of abbreviations: LDH, lactate dehydrogenase; LLC, Lewis lung cancer; MPE, malignant pleural effusion; VEGF, vascular endothelial growth factor.

Values represent mean ± SEM.